What are the considerations for labetalol use in patients with chronic liver disease and how does liver function influence its pharmacokinetics?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Labetalol is metabolized by the liver, so in chronic liver disease, its clearance is reduced. This necessitates careful dose adjustment and monitoring for toxicity.